Sanofi Sa

Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children

Sanofi: Information concerning the total number of voting rights and shares - March 2026

Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria

Sanofi becomes market authorization holder for Nuvaxovid® in Canada, expanding COVID-19 vaccine choices for Canadians

Sanofi - Combined General Meeting of April 29, 2026 - Availability of Preparatory documents